The Loev Law Firm, PC advised Mangoceuticals and Olshan Frome Wolosky LLP Boustead Securities, LLC, as sole managing underwriter on the IPO. Mangoceuticals, Inc. (“MangoRx” or...
Mangoceuticals’ $5 Million Initial Public Offering
Jeffrey R. Westphal’s $23 Million Block Trade Offering of Vertex
Olshan Frome Wolosky LLP represented Jeffrey R. Westphal, Latham & Watkins LLP represented Vertex and Skadden, Arps, Slate, Meagher & Flom LLP represented Goldman Sachs. Jeffrey...
Blink Charging’s $200 Million Acquisition of SemaConnect
Olshan Frome Wolosky acted as counsel to Blink Charging Co., while DLA Piper advised SemaConnect on the deal. SemaConnect, Inc., a leading provider of electric vehicle...
Blink Charging’s $200 Million Acquisition of SemaConnect
Olshan Frome Wolosky acted as counsel to Blink Charging Co., while DLA Piper advised SemaConnect on the deal. SemaConnect, Inc., a leading provider of electric vehicle...
Star Equity Holdings’ $14.25 Million Common Stock Offering
Olshan Frome Wolosky represented Star Equity Holdings in the offering. Star Equity Holdings, Inc. (Nasdaq: STRR; STRRP) closed its underwritten public offering of 9,500,000 shares of its common...
Alzamend Neuro’s $14.4 Million Initial Public Offering
Olshan Frome Wolosky LLP advised Alzamend Neuro and Ault Global Holding, while Haynes & Boone LLP represented the underwriter in the offering. Alzamend Neuro, Inc. executed...
Anebulo Pharmaceuticals’ $21 Million Initial Public Offering
Olshan Frome Wolosky LLP advised Anebulo Pharmaceuticals on the deal. Anebulo Pharmaceuticals, Inc. executed its $21 million initial public offering and listing on The Nasdaq Capital Market...
Anebulo Pharmaceuticals’ $21 Million Initial Public Offering
Olshan Frome Wolosky LLP advised Anebulo Pharmaceuticals on the deal. Anebulo Pharmaceuticals, Inc. executed its $21 million initial public offering and listing on The Nasdaq Capital Market...
IMAC’s $19.55 Million Shares Offering
Olshan Frome Wolosky LLP advised IMAC Holdings on the offering. IMAC Holdings, Inc. (Nasdaq: IMAC) executed a $19.55 million underwritten follow-on public offering of its shares...